Navigation Links
Lauren Sciences independently recognized as a Technology Innovator in Drug Delivery with its V-Smart™ Platform, and selected as a Featured Company, in new report by MCD Group
Date:6/18/2013

New York, N.Y., June 18, 2013 -- Lauren Sciences, a privately-held biotechnology company furthering development of its novel V-Smart nanovesicle platform technology, announced today that it was independently recognized as a Technology Innovator in Drug Delivery with its V-Smart Platform, and selected as a Featured Company, in a new report by MCD Group.

The report, "Early Stage Drug Delivery Technologies: Profiles of Start-ups and Emerging Companies," features companies MCD Group independently selected as technology innovators that could potentially transform drug delivery in one or more therapeutic areas. Lauren Sciences was selected based on its groundbreaking work to-date in achieving delivery of a variety of drugs and biologics across the blood brain barrier (BBB). The MCD Group report includes an in-depth profile of Lauren Sciences, providing a scientific description of the V-Smart technology and detailed information on its V-Smart therapeutic programs in central nervous system (CNS) diseases such as Parkinson's disease, neuro-HIV and brain cancer.

"The inclusion of Lauren Sciences in the MCD Group report is yet another independent acknowledgement of the potential of Lauren Sciences and our innovative V-Smart drug delivery technology," said Susan Rosenbaum, J.D., Chairman and Chief Executive Officer of Lauren Sciences. "We expect that this recognition will foster new strategic partnerships within the pharmaceutical industry for Lauren Sciences and, thus, further development of transformative V-Smart therapeutics for CNS-disease patients."


'/>"/>

Contact: Susan Rosenbaum
srosenbaum@laurensciences.com
212-737-0455
Lauren Sciences LLC
Source:Eurekalert

Page: 1

Related medicine news :

1. Lauren Sciences LLCs research team at Ben-Gurion University awarded Campbell Foundation grant to develop a V-Smart therapeutic for neuro-HIV
2. Washingtons Life Sciences Discovery Fund awards commercialization grants
3. Hutchinson Center president elected to American Academy of Art and Sciences
4. Ivy Neurological Sciences Internship program funded at TGen
5. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
6. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
7. Novel Natural Sciences Repository Opens Web Portal
8. New Anthropology and Archaeology Resources Published at Sciences Social Network
9. Natural Sciences Repository Publishes Chromatography and Acidic Compounds Resources
10. Life Sciences Discovery Fund makes company grants in health-related technologies
11. Wits Health Sciences Research Day and PG Expo promises to showcase health through research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: